Mina Xu

Mina Xu, MD, is a Professor of Pathology and Laboratory Medicine at Yale School of Medicine, where she serves as Director of Hematopathology and Director of the Expert Consultation Practice. Her clinical expertise focuses on diagnosing blood cancers such as lymphoma, leukemia, and myeloma, integrating molecular genetic testing and microscopic analysis.

• BA in Biology, Harvard University (2000)
• MD, University of California at San Francisco (2006)
• Residency, Yale-New Haven Hospital (2010)
• Fellowship, Brigham & Women's Hospital (2011)

Dr. Xu’s research interests center on hematopathology, with emphasis on:

• Biomarker Discovery (e.g., IRF8, CD123)
• Bone Marrow and Lymphoma Diagnostics
• Spatial Transcriptomics and Liquid Biopsy Applications
• Classification of Myelodysplastic Syndromes

Her recent publications highlight advancements in spatial CITE-seq for tumor mapping, liquid biopsy for ctDNA analysis, and immune evasion mechanisms in AML. Notable collaborations include work with Stephanie Halene, Amer Zeidan, and Nikolai Podoltsev.

Scientific Awards

• American Society of Hematology Trainee Grant (2005)
• Weizmann Institute of Science Scholarship (1996)
• Westinghouse Science Award (1996)
• National Science Foundation Trainee Grant (1994)

Dr. Xu leads the Hematopathology Lab at Yale Cancer Center, contributing to clinical trials and translational research. She advocates for pathologist-patient communication and integrating genomic data into diagnostic workflows.